Abstract: Fake medicines are not a new thing for a health care professional. Counterfeit drugs cause significant public health hazard and raise safety concerns. They may contain only inactive ingredients, incorrect ingredients, improper dosages, sub-therapeutic or super-therapeutic agents, or simply be contaminated. As a consequence, the patients may be at risk for serious adverse effects on health. Sometimes counterfeiters switch lower-strength drug for higher strength drug. As a result, patients get lower than expected doses of a particular medicine, leading to ineffective treatment or total therapeutic failure. Counterfeiting of medicines is widespread and affects both developing and developed countries.
During the past few decades, a number of pharmaceutical manufacturers and distributors have crop up worldwide, leading to the large number of drug products flourishing in national and international markets. Due to this, a large number of preventive and curative medicines are now available to fight diseases. Similarly, highly sensitive and sophisticated analytical methods have been developed to ensure the quality of drugs. However, despite all the advancements made so far, the presence of counterfeit and substandard drugs has increased substantially as a result of ineffective regulation of the manufacture of and trade in pharmaceutical products by both exporting and importing countries. |
The above content is an abstract only. For the full Article please contact:
KONGPOSH Publications Pvt. Ltd.
ICS House, C-19, Commercial Complex, SDA, Opp. IIT Gate, New Delhi, India -110016
Tel.: 26855839, 20057149, Fax: 91-11-26855876
Email:
info@kppub.com /
fpc@vsnl.com, Website:
http://www.kppub.com |
